Company intelligence / Profile preview

Previvo Genetics

Ownership: Private
Development stage: Commercial

Overview

The company has developed a novel uterine lavage system to recover in vivo fertilized and matured preimplantation human embryos. In clinical studies, the device achieved an embryo recovery efficiency of approximately 42% across eleven cohorts. Most recovered blastocysts were of good morphology. The technology enables genetic analysis of embryos prior to implantation without traditional IVF. The company also operates a longevity clinic offering personalized health programs.

Therapeutic areas: OtherRare DiseasesWomen's Health
Modalities: Device (specifically, uterine lavage system for embryo recovery)
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on Previvo Genetics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Previvo Genetics.

Explore the full profile